Table 2 Baseline demographic and anamnestic parameters (ITT population)
Baseline Parameter | Test group (MCT/LCT/FO-derived n-3 PUFAs) N = 21 | Control group (MCT/LCT) N = 21 | p-value |
|---|---|---|---|
Age (years, mean ± SD) | 55.8 ± 15.1 | 58 ± 13.0 | 0.6160 |
Male / Female (%) | 66.7 / 33.3 | 57.1 / 42.9 | – |
Weight (kg, mean ± SD) | 62.7 ± 12.3 | 63.2 ± 10.1 | 0.9001 |
Height (cm, mean ± SD) | 170.6 ± 9.9 | 174.1 ± 9.7 | 0.2523 |
BMI (kg/m2, mean ± SD) | 21.4 ± 2.6 | 20.8 ± 2.3 | 0.4041 |
Diseases within last 3 months before study start (%) | 76.2 | 100 | 0.0478 |
Concomitant diseases at study start (%) | 85.7 | 100 | 0.2317 |
Concomitant medication at study start (%) | 100 | 95.2 | 1.000 |
Oncological disease (%) | 52.4 | 61.9 | 0.7557 |
Chemotherapy during last year (%) | 14.3 | 23.8 | 0.6965 |
Radiation therapy during last year (%) | 0 | 9.5 | 0.4878 |
Other tumor therapy during last year (%) | 19.0 | 14.3 | 1.000 |
Weight loss during the last three months (%) | 42.9 | 47.6 | 1.000 |
Nicotine consumption (%) | 38.1 | 33.3 | 1.000 |
Alcohol abuse (%) | 4.8 | 0 | 1.000 |
Drug abuse (%) | 0 | 0 | NA |
On diet (not specified) before study start (%) | 0 | 4.8 | 1.000 |